Discontinuation report CASODEX
Report ID | 231878 |
Drug Identification Number | 02184478 |
Brand name | CASODEX |
Common or Proper name | bicalutamide |
Company Name | ASTRAZENECA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BICALUTAMIDE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tablets |
ATC code | L02BB |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2025-01-02 |
Actual discontinuation date | |
Remaining supply date | 2025-01-02 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-07-02 | French | Compare |
v1 | 2024-07-02 | English | Compare |
Showing 1 to 2 of 2